Mechanism of enhancement effect of dendrimer on transdermal drug permeation through polyhydroxyalkanoate matrix.

The possible application of polyhydroxyalkanoate (PHA) in transdermal drug delivery systems (TDDSs) for tamsulosin was previously reported. PHAs containing the drugs, ketoprofen, clonidine and tamsulosin showed good adhesiveness to the skin model used, that is, shed snake skin, and dispersed well all model drugs tested. The model drugs hardly permeated through snake skin in solution form. However, these drugs permeated well through snake skin from the PHA matrix. It was previously reported that the addition of a dendrimer, a polymeric permeation enhancer, is effective for the TDDS for tamsulosin to establish an effective clinical TDDS. The effect of dendrimer addition was examined in TDDSs for ketoprofen and clonidine. The dendrimer added did not show an enhancement effect on the TDDSs for the two drugs. To investigate the mechanism of the enhancement effect of a dendrimer on the tamsulosin TDDS, X-ray analyses were performed. With dendrimer addition, drug crystallization in PHA was promoted. The crystal in PHA had highly ordered and changed its space group. These findings are very important for exploiting high-performance PHA-based TDDSs.

[1]  M. Shintani,et al.  Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. , 1990, Journal of pharmaceutical sciences.

[2]  Gjalt W. Huisman,et al.  Metabolic Engineering of Poly(3-Hydroxyalkanoates): From DNA to Plastic , 1999, Microbiology and Molecular Biology Reviews.

[3]  Colin W. Pouton,et al.  Biosynthetic polyhydroxyalkanoates and their potential in drug delivery , 1996 .

[4]  G. Huisman,et al.  Pseudomonas putida KT2442 cultivated on glucose accumulates poly(3-hydroxyalkanoates) consisting of saturated and unsaturated monomers , 1992, Applied and environmental microbiology.

[5]  A. Sinskey,et al.  Poly-beta-hydroxybutyrate (PHB) biosynthesis in Alcaligenes eutrophus H16. Identification and characterization of the PHB polymerase gene (phbC). , 1989, The Journal of biological chemistry.

[6]  A. Anderson,et al.  Occurrence, metabolism, metabolic role, and industrial uses of bacterial polyhydroxyalkanoates. , 1990, Microbiological reviews.

[7]  Yoshihisa Nakano,et al.  Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine dendrimer. , 2003, Journal of bioscience and bioengineering.

[8]  S. Lee,et al.  Comparison of recombinant Escherichia coli strains for synthesis and accumulation of poly‐(3‐hydroxybutyric acid) and morphological changes , 1994, Biotechnology and bioengineering.

[9]  M. Okazaki,et al.  A NEW SPECIES OF HYDROGEN-UTILIZING BACTERIUM , 1979 .

[10]  A. Steinbüchel,et al.  Formation of polyesters consisting of medium-chain-length 3-hydroxyalkanoic acids from gluconate by Pseudomonas aeruginosa and other fluorescent pseudomonads , 1990, Applied and environmental microbiology.

[11]  A. Steinbüchel,et al.  Diversity of bacterial polyhydroxyalkanoic acids , 1995 .

[12]  Ju-Hyun Kim,et al.  Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. , 2002, International journal of pharmaceutics.

[13]  A. Steinbüchel,et al.  Cloning and molecular analysis of the poly(3-hydroxyalkanoic acid) gene locus of Pseudomonas aeruginosa PAO1. , 1992, European journal of biochemistry.

[14]  J. Hadgraft.  Skin, the final frontier. , 2001, International journal of pharmaceutics.

[15]  Sang Yup Lee,et al.  Production of Poly(3-Hydroxybutyrate) by Fed-Batch Culture of Recombinant Escherichia coliwith a Highly Concentrated Whey Solution , 2000, Applied and Environmental Microbiology.

[16]  P. de Waard,et al.  13C nuclear magnetic resonance studies of Pseudomonas putida fatty acid metabolic routes involved in poly(3-hydroxyalkanoate) synthesis , 1994, Journal of bacteriology.